New therapy aims to ease cancer Survivors' fear of return
NCT ID NCT06676228
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This study adapted a 6-session behavioral therapy called FORT for Turkish breast and ovarian cancer survivors to help them manage fear of cancer recurrence. Researchers worked with 100 participants to translate and test the therapy, measuring changes in fear, anxiety, and quality of life. The goal is to provide a culturally suitable tool to support survivors' mental health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istanbul Maltepe University
Istanbul, Turkey (Türkiye)
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fear of cancer recurrence therapy (FORT) - a 6-session behavioral intervention
What this could lead to
If successful, this culturally adapted therapy could provide an effective way to reduce fear of cancer recurrence and improve mental well-being for Turkish cancer survivors.
What could go wrong
This is a small, completed cultural adaptation study with 100 participants, so results may not apply broadly. The therapy's long-term benefits beyond 6 months are not yet known.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.